Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William U Makupa

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Eye (London, England)|May 19, 2022
Gender bias within a diabetic retinopathy screening programme in TanzaniaCharles R Cleland, Cristovao Matsinhe, William U Makupa, et al.
Ophthalmic Epidemiology|September 14, 2019
Severity of Visual Field Loss at First Presentation to Glaucoma Clinics in England and TanzaniaPete R Jones, Heiko Philippin, William U Makupa, et al.
The Lancet. Global Health|February 18, 2022
Selective laser trabeculoplasty for glaucoma in sub-Saharan Africa - Author's replyHeiko Philippin, David Macleod, Einoti Matayan, et al.
Tropical Medicine & International Health : TM & IH|December 9, 2015
Diabetic retinopathy in Tanzania: prevalence and risk factors at entry into a regional screening programmeCharles R Cleland, Matthew J Burton, Claudette Hall, et al.
The Lancet. Diabetes & Endocrinology|December 15, 2015
Diabetic retinopathy screening: experiences from northern TanzaniaCharles R Cleland, Matthew J Burton, Claudette Hall, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 16, 2024
Implementing an artificial intelligence system into a diabetic eye screening programme in TanzaniaCharles R Cleland, William U Makupa, Bernadetha R Shilio, et al.
BMC Ophthalmology|July 21, 2016
Reasons for poor follow-up of diabetic retinopathy patients after screening in Tanzania: a cross-sectional studyChristina Mtuya, Charles R Cleland, Heiko Philippin, et al.
Value in Health Regional Issues|June 2, 2026
Quality-of-Life and Utility Values Associated With Diabetic Retinopathy in TanzaniaCharles R Cleland, Anna P Marques, John Cairns, et al.
Diabetes Care|June 10, 2026
Head-to-Head Comparative Evaluation of Four Commercially Available Artificial Intelligence Systems for Detecting Referable Diabetic Retinopathy in a Tanzanian PopulationCharles R Cleland, Covadonga Bascaran, William U Makupa, et al.
The Lancet. Global Health|October 16, 2021
Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trialHeiko Philippin, Einoti Matayan, Karin M Knoll, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Eye (London, England)|May 19, 2022
Gender bias within a diabetic retinopathy screening programme in TanzaniaCharles R Cleland, Cristovao Matsinhe, William U Makupa, et al.
Ophthalmic Epidemiology|September 14, 2019
Severity of Visual Field Loss at First Presentation to Glaucoma Clinics in England and TanzaniaPete R Jones, Heiko Philippin, William U Makupa, et al.
The Lancet. Global Health|February 18, 2022
Selective laser trabeculoplasty for glaucoma in sub-Saharan Africa - Author's replyHeiko Philippin, David Macleod, Einoti Matayan, et al.
Tropical Medicine & International Health : TM & IH|December 9, 2015
Diabetic retinopathy in Tanzania: prevalence and risk factors at entry into a regional screening programmeCharles R Cleland, Matthew J Burton, Claudette Hall, et al.
The Lancet. Diabetes & Endocrinology|December 15, 2015
Diabetic retinopathy screening: experiences from northern TanzaniaCharles R Cleland, Matthew J Burton, Claudette Hall, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 16, 2024
Implementing an artificial intelligence system into a diabetic eye screening programme in TanzaniaCharles R Cleland, William U Makupa, Bernadetha R Shilio, et al.
BMC Ophthalmology|July 21, 2016
Reasons for poor follow-up of diabetic retinopathy patients after screening in Tanzania: a cross-sectional studyChristina Mtuya, Charles R Cleland, Heiko Philippin, et al.
Value in Health Regional Issues|June 2, 2026
Quality-of-Life and Utility Values Associated With Diabetic Retinopathy in TanzaniaCharles R Cleland, Anna P Marques, John Cairns, et al.
Diabetes Care|June 10, 2026
Head-to-Head Comparative Evaluation of Four Commercially Available Artificial Intelligence Systems for Detecting Referable Diabetic Retinopathy in a Tanzanian PopulationCharles R Cleland, Covadonga Bascaran, William U Makupa, et al.
The Lancet. Global Health|October 16, 2021
Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trialHeiko Philippin, Einoti Matayan, Karin M Knoll, et al.
Pageof 2